Lundbeck

www.lundbeck.com

Ottiliavej 9
Valby
DK-2500
Denmark

+45 4371 4270

Activities

Pharmaceutical

Related Companies

Related Content

Domain Therapeutics receives $125m to assign its intellectual property
Domain Therapeutics receives $125m to assign its intellectual property
Moving to continuous processes
Moving to continuous processes
Lundbeck embarks on another restructuring to drive profit and ensure growth
Lundbeck embarks on another restructuring to drive profit and ensure growth
Alzheimer’s treatment market value to exceed US$13bn by 2023
Alzheimer’s treatment market value to exceed US$13bn by 2023
Kåre Schultz appointed as President and CEO of Lundbeck
Kåre Schultz appointed as President and CEO of Lundbeck
Ulf Wiinberg resigns as CEO of Lundbeck
Ulf Wiinberg resigns as CEO of Lundbeck
Lundbeck to buy Chelsea Therapeutics for US$658m
Lundbeck to buy Chelsea Therapeutics for US$658m
NCEs target cancer
NCEs target cancer
New products drive growth at Lundbeck in 2013
New products drive growth at Lundbeck in 2013
Lundbeck secures funding from The Michael J Fox Foundation
Lundbeck secures funding from The Michael J Fox Foundation
Competition Law is catching pharma companies out
Competition Law is catching pharma companies out
Lundbeck appeals against €93.8m fine
Lundbeck appeals against €93.8m fine
Lundbeck to restructure and cut jobs in Europe
Lundbeck to restructure and cut jobs in Europe
Drug approvals: more numerous but niche
Drug approvals: more numerous but niche
Antidepressant – vortioxetine
Antidepressant – vortioxetine